Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity
Sarah Pogue(Biolog (United States)), David S. Wilson(Johns Hopkins University)
Cited by 59
Related Papers
The Receptor for Type I IFNs Is Highly Expressed on Peripheral Blood B Cells and Monocytes and Mediates a Distinct Profile of Differentiation and Activation of These Cells
|Journal of Interferon & Cytokine Research|2004|63